Nonsurgical management of resectable oral cavity cancer in the wake of COVID-19: A rapid review and meta-analysis
- 1 October 2020
- journal article
- review article
- Published by Elsevier in Oral Oncology
- Vol. 109, 104849
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Multicenter phase II trial of preoperative chemoradiotherapy with S-1 for locally advanced oral squamous cell carcinomaCancer Chemotherapy and Pharmacology, 2013
- Follow up after IMRT in oral cavity cancer: updateRadiation Oncology, 2012
- Preoperative concurrent chemoradiotherapy for stages II–IV oral squamous cell carcinoma: a retrospective analysis and the future possibility of this treatment strategyInternational Journal of Oral and Maxillofacial Surgery, 2012
- Impact of Treatment Sequence of Multimodal Therapy for Advanced Oral Cavity Cancer with Mandible InvasionOtolaryngology–Head and Neck Surgery, 2011
- Low-Dose Preoperative Chemoradiation Therapy Compared with Surgery Alone with or Without Postoperative Radiotherapy in Patients with Head and Neck CarcinomaAnnals of Surgical Oncology, 2011
- Induction Chemotherapy Before Chemoradiotherapy in Locally Advanced Head and Neck Cancer: The Future?The Oncologist, 2010
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEuropean Journal of Epidemiology, 2010
- Risk factors affect the survival outcome of hard palatal and maxillary alveolus squamous cell carcinoma: 10-year review in a tertiary referral centerOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 2010
- Chemoradiation for patients with advanced oral cavity cancerThe Laryngoscope, 2009
- Importance of Comorbidity in Head and Neck CancerThe Laryngoscope, 2000